Add BrightSurf on Google Email

Family Heart Foundation announces results of real-world study in 273,770 individuals with cardiovascular disease demonstrating that risk of subsequent cardiovascular event increases with rising lipoprotein(a) levels

A study of 273,770 individuals with cardiovascular disease found that increasing lipoprotein(a) levels significantly increases the risk of subsequent cardiovascular events. Treatment with high-impact LDL-C lowering therapies may help reduce this risk.

SourceFamily Heart Foundation·JournalEuropean Heart Journal·TypeData/statistical analysis·DateMay 7, 2025

Is your heart aging too fast?

A new MRI technique measures a person's 'functional age' of their heart, revealing how unhealthy lifestyles add years to their heart's aging process. This method has the potential to transform heart disease diagnosis and offer a lifeline to millions by catching problems early.

SourceUniversity of East Anglia·JournalOpen Heart·TypeObservational study·DateMay 1, 2025

Mechanical heart valve replacements have better long-term survival, study finds

A new study published in the European Journal of Cardio-Thoracic Surgery found that mechanical heart valve replacements have better long-term survival rates compared to biological valves. Patients who received mechanical valves had improved survival up to 13 years after surgery, with smaller valves showing greater benefits.

SourceUniversity of Bristol·JournalEuropean Journal of Cardio-Thoracic Surgery·TypeObservational study·DateFeb 11, 2025

How improving education could close maternal heart health gaps

A new Northwestern University study reveals that achieving equity in social drivers of health, particularly education, can nearly eliminate the gap in heart health between Black and white women. The study found that educational attainment had the largest impact on maternal cardiovascular health disparities. Improving access to healthy ...

SourceNorthwestern University·JournalCirculation Cardiovascular Quality and Outcomes·DateJan 15, 2025

The heart has its own ‘brain’

Researchers at Karolinska Institutet and Columbia University identified a mini-brain within the heart with its own nervous system that controls the heartbeat. This discovery challenges current views on how the heartbeat is controlled and may lead to new insights into heart diseases and treatments.

SourceKarolinska Institutet·JournalNature Communications·TypeExperimental study·DateDec 4, 2024

With $12 million NIH grant renewal, Lewis Katz School of Medicine researchers to explore novel cell mechanism in heart injury and repair

Researchers at the Lewis Katz School of Medicine will investigate how injured heart cells communicate with other cells throughout the body using microvesicles known as exosomes. The study aims to understand how specific molecules, such as microRNAs, facilitate communication pathways between cells in the heart and vasculature.

ChatGPT fails at heart risk assessment

A study by Washington State University found ChatGPT's generative AI system provided inconsistent heart risk assessments for patients with chest pain. The AI failed to match traditional methods used by physicians and returned different results for the same patient data, highlighting its limitations in high-stakes clinical situations.

SourceWashington State University·JournalPLOS ONE·DateMay 1, 2024

Shorten the blanking period after atrial fibrillation ablation, experts say

Research published in Heart Rhythm suggests that the three-month blanking period after atrial fibrillation (AF) ablation may not be necessary, as early AF recurrence is a predictor of late recurrence. The authors propose shortening the blanking period to one month, citing studies that show higher risks of long-term recurrence for patie...

SourceElsevier·JournalHeart Rhythm·TypeData/statistical analysis·DateApr 17, 2024

Unnecessary use of beta-blockers after a heart attack

A new study published in the New England Journal of Medicine found that half of patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. The study shows that these patients have suffered a small heart attack and have retained heart function afterwards.

SourceKarolinska Institutet·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 8, 2024

Treating anxiety, depression significantly impacts heart disease outcomes

A new study from Ohio State University Wexner Medical Center found that treating anxiety and depression significantly improves heart disease outcomes, with a 75% reduction in hospitalizations or emergency room visits. The study suggests a collaborative care model is essential for managing cardiovascular and mental health.

SourceOhio State University Wexner Medical Center·JournalJournal of the American Heart Association·DateMar 20, 2024

Halting a malformation of the heart

A team of scientists has identified the molecular switches involved in halting heart malformations, which could lead to new treatments for tetralogy of Fallot. By targeting the BBLN protein, they aim to prevent defects in four critical areas of the heart.

SourceETH Zurich·JournalNature Cardiovascular Research·TypeExperimental study·DateNov 22, 2023

In historic procedure, donor liver protects heart transplant

In a groundbreaking procedure, Adriana Rodriguez received a dual-organ transplant, with her healthy liver transplanted into another patient to mitigate rejection risk. This innovative approach, known as HALT-D, demonstrates the potential for immunoprotection and has implications for highly sensitized patients requiring multiple organs.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalThe Journal of Heart and Lung Transplantation·TypeCase study·DateJul 13, 2023

Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease

A new study found that elevated Lipoprotein(a) levels are a significant predictor of recurrent coronary heart disease (CHD) in people over 60. The study suggests current cholesterol-lowering medications may not be effective in reducing the risk of recurrent CHD, highlighting the need for novel therapeutics to target elevated Lp(a).

SourceTaylor & Francis Group·JournalCurrent Medical Research and Opinion·TypeObservational study·DateJun 13, 2023

A ribosomal traffic jam that breaks the heart

Researchers found that a mutation in RPL3L, expressed only in heart and skeletal muscle, leads to impaired cardiac contractility by causing ribosomal collisions and protein folding abnormalities. The study aims to develop new treatments for cardiomyopathy and atrial fibrillation.

SourceKyushu University·JournalNature Communications·TypeExperimental study·DateMay 18, 2023

National study suggests it’s time to rethink how we treat atrial fibrillation

A national study published in The New England Journal of Medicine finds that early intervention with catheter cryoablation can halt disease progression and reduce serious health risks. Cryoablation is more effective than antiarrhythmic drugs in reducing the risk of persistent AF, hospitalization, and adverse events.

SourceUniversity of British Columbia·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 7, 2022